Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity.

Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE.

Am J Clin Nutr. 2006 Jun;83(6 Suppl):1483S-1493S.

2.

Bioactive lipids in schizophrenia.

Berger GE, Smesny S, Amminger GP.

Int Rev Psychiatry. 2006 Apr;18(2):85-98. Review.

PMID:
16777663
3.

Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.

Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH.

Am J Psychiatry. 2006 Jun;163(6):1098-100.

PMID:
16741212
4.

Omega-3 fatty acids and mood disorders.

Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D.

Am J Psychiatry. 2006 Jun;163(6):969-78. Review. Erratum in: Am J Psychiatry. 2006 Oct;163(10):1842.

PMID:
16741195
5.
6.

Cytokines sing the blues: inflammation and the pathogenesis of depression.

Raison CL, Capuron L, Miller AH.

Trends Immunol. 2006 Jan;27(1):24-31. Epub 2005 Nov 28. Review.

7.

One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats.

DeMar JC Jr, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI.

J Lipid Res. 2006 Jan;47(1):172-80. Epub 2005 Oct 6.

8.

Nutrition and schizophrenia.

Peet M.

World Rev Nutr Diet. 2005;95:17-28. Review. No abstract available.

PMID:
16151267
9.

Omega-3 fatty acids and neuropsychiatric disorders.

Young G, Conquer J.

Reprod Nutr Dev. 2005 Jan-Feb;45(1):1-28. Review.

PMID:
15865053
10.

Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life.

Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, Aïd S, Poumès-Ballihaut C, Champeil-Potokar G, Lavialle M.

Reprod Nutr Dev. 2004 Nov-Dec;44(6):509-38. Review.

PMID:
15762297
12.

Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat.

Kodas E, Galineau L, Bodard S, Vancassel S, Guilloteau D, Besnard JC, Chalon S.

J Neurochem. 2004 May;89(3):695-702.

13.

Dietary intake of n-3, n-6 fatty acids and fish: relationship with hostility in young adults--the CARDIA study.

Iribarren C, Markovitz JH, Jacobs DR Jr, Schreiner PJ, Daviglus M, Hibbeln JR.

Eur J Clin Nutr. 2004 Jan;58(1):24-31.

PMID:
14679363
14.

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

Su KP, Huang SY, Chiu CC, Shen WW.

Eur Neuropsychopharmacol. 2003 Aug;13(4):267-71. Erratum in: Eur Neuropsychopharmacol. 2004 Mar;14(2):173.

PMID:
12888186
15.

A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression.

Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ.

Am J Psychiatry. 2003 May;160(5):996-8.

PMID:
12727707
16.
17.

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.

Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association. Nutrition Committee.

Circulation. 2002 Nov 19;106(21):2747-57. No abstract available. Erratum in: Circulation. 2003 Jan 28;107(3):512..

20.

The effect of docosahexaenoic acid on aggression in elderly Thai subjects--a placebo-controlled double-blind study.

Hamazaki T, Thienprasert A, Kheovichai K, Samuhaseneetoo S, Nagasawa T, Watanabe S.

Nutr Neurosci. 2002 Feb;5(1):37-41.

PMID:
11929196

Supplemental Content

Support Center